Ischaemic stroke


Disease modifying treatment available:
Time critical diagnosis and management:
Lateralising:


Taxotomy

Supercategory
Stroke
Subclassifications Epidemiology Clinical features
Posterior inferior cerebellar artery occlusion None
Anterior inferior cerebellar artery occlusion None Vertigo
Sensorineural hearing loss
Anterior cerebral artery occulsion None



Aetiology

Disorder Clinical features Associated features Investigations Disease modifying treatment available Time critical
Atrial fibrillation
Hypertension Chronic kidney disease
Headache
Posterior reversible encephalopathy syndrome
Acute promyelocytic leukemia Splenic infarction
Arterial dissection
Aortic dissection Abdominal pain
Chest pain
Seizure
Cardiogenic syncope



Associated Disorders





Clinical features



Ischaemic stroke may cause the following:





Treatment


In people presenting with acute ischaemic stroke the most important initial decision is regarding if a reperfusion therapy (thrombolysis or thrombectomy) is likely to be of benefit.

Pharmacological thrombolysis should be considered in those with acute ischaemic stroke with a deficit for less than 4.5 hours. Thrombolysis is not offered to those who are already therapeutically anticoagulated. If the blood pressure is 185/110mmHg or greater this should be lowered before giving thrombolysis. Meta-analysis has confirmed that even patients with a low NIHSS benefit from thrombolysis.

Mechanical thrombectomy should be considered in those presenting with a deficit of less than 6 hours. This time windows extends to 24 hours if there is basilar occlusion or favourable neuroimaging. Typically a reasonable pre-morbid baseline is required (e.g. mRS 0-2) and an NIHSS score > 6. The initial CT brain should not show any haemorrhage or evidence of major ischaemic changes (eASPECTS >= 6). CT angiogram should demonstrate a large vessel occlusion.

In those presenting within 6 - 24 hours, mechanical thrombectomy can be considered in those with significant salvageable tissue on CT perfusion.

Blood glucose should be tested as soon a neurological deficit is identified and treated if low.


Pharmacological treatments




Research


Open questions

Lots of questions remain about the optimal management of ischaemic stroke secondary to arterial dissection:
- Are anticoagulant and antiplatelet therapy equivalent in terms of risk and do individual drugs within these classes offer any advantage?
- What is the optimal duration for pharmacological therapy?
- If aneurysmal outpouching develops post dissection does this have implications for the nature or duration of treatment?
- Is thrombolysis safe and effective?